Welcome to our dedicated page for Safer Shot news (Ticker: SAFS), a resource for investors and traders seeking the latest updates and insights on Safer Shot stock.
Safer Shot (SAFS) delivers innovative nutraceutical solutions focused on alcohol metabolism support through clinically validated formulations. This news hub provides investors and industry stakeholders with essential updates about the company’s scientific advancements, market strategies, and product developments.
Access real-time announcements covering clinical research milestones, distribution partnerships, and packaging innovations. Our curated collection includes earnings reports, regulatory updates, and analyses of SAFS’ dual-channel business model serving both consumers and hospitality businesses.
Key updates feature developments in powdered supplement technology, B2B collaborations with bars/restaurants, and advancements in stick-pack delivery systems. Bookmark this page to monitor how SAFS continues to redefine portable wellness solutions through rigorous R&D and strategic industry engagement.
Safety Shot, Inc. (Nasdaq: SAFS) is set to launch a powdered version of its alcohol-reducing product in early Q4. The new format, available in convenient stick packs, maintains the full efficacy of the original formula. This innovation addresses a growing market for stick packaging solutions, projected to reach $517.61 million by 2031.
The powder stick packs will be sold in packs of 6, with single stick options available at select locations. This format expansion aims to increase brand visibility, broaden the customer base, and offer greater convenience for consumers looking to reduce their blood alcohol content in as little as 30 minutes.
FAQ
What is the current stock price of Safer Shot (SAFS)?
What is the market cap of Safer Shot (SAFS)?
